GDF11 Binding Aptamer Specificity via Local Epitope Recognition

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current protein binding reagents struggle to distinguish between growth differentiation factor 11 (GDF11) and myostatin (GDF8) due to their homology, making it difficult to measure and localize these proteins effectively in development and adult tissues.

Innovation Solution

Development of aptamers with specific binding affinity to GDF11, exhibiting an equilibrium binding constant of less than 100 nM, and significantly weaker affinity for GDF8, allowing for precise detection and differentiation of GDF11 in samples.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If current protein binding reagents (antibodies) are used to detect GDF11, then general protein detection is possible, but specificity to distinguish GDF11 from GDF8 is lost due to their homology

Engineering Contradiction:
Improvedetection specificityVSAvoidprotein differentiation difficulty
Core Design Contradiction:
Measurement precisionVSDifficulty of detecting and measuring

Solution Approach 1:

The aptamer is designed to recognize and bind to a specific local region (epitope) on the GDF11 protein that is structurally distinct from GDF8, despite their overall homology. This localized recognition enables specific detection of GDF11 without cross-reactivity with GDF8, resolving the contradiction between general detection capability and specific differentiation.

Inventive Principle:
Principle #3Local quality

2Reliability

If high affinity binding is achieved for GDF11 detection, then sensitivity is improved, but cross-binding to homologous GDF8 may increase

Engineering Contradiction:
Improvebinding affinityVSAvoidbinding specificity
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

The GDF11 protein surface is effectively segmented into distinct binding regions, and the aptamer is designed to target a specific segment that is unique to GDF11. This segmentation approach allows the aptamer to achieve high binding affinity for GDF11 while maintaining specificity by avoiding regions that are homologous to GDF8.

Inventive Principle:
Principle #1Segmentation

3Measurement precision

If aptamers are designed for high specificity to GDF11, then measurement accuracy is improved, but the complexity of aptamer selection and validation increases

Engineering Contradiction:
Improvedetection accuracyVSAvoidaptamer development complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

Instead of directly designing and validating complex aptamers from scratch, the invention uses a library of synthesized aptamer sequences that are screened against GDF11. This copying approach through systematic library screening simplifies the development process while still achieving high specificity, as the screening process efficiently identifies aptamers with the desired binding characteristics.

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The aptamers effectively bind GDF11 with high specificity and low affinity for GDF8, enabling accurate detection and measurement of GDF11 in various samples, overcoming the challenges posed by protein homology.

Implementation Method 1

a composition comprising an aptamer and a GDF11 protein, wherein the aptamer and the GDF11 protein are bound by a non-covalent interaction

Methodology Applied
Scientific EffectNon-covalent interaction:

Data Source

PatentUS11535852B2Nucleic acid compounds for binding growth differentiation factor 11
Publication Date: 2022.12.27 SOMALOGIC OPERATING CO INC
  • US11535852B2 patent drawing
  • US11535852B2 patent drawing
  • US11535852B2 patent drawing

AI summary

Described herein are aptamers capable of binding to growth differentiation factor 11 (GDF11) protein; compositions comprising a GDF11 binding aptamer with a GDF11 protein; and methods of making and using the same.